Report cover image

Global Gene Fusion Testing Market

Publisher BCC Research
Published Dec 24, 2025
Length 79 Pages
SKU # WA20686032

Description

Report Scope

The report provides an overview of the gene fusion testing market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025 and projected data for 2026 through 2030.

The market is segmented by technology, indication and end user. By technology, the market is segmented into fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), polymerase chain reaction (PCR) and immunohistochemistry (IHC). By indication, it is segmented into hematological cancer and solid tumor. By end user, the market comprises pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, as well as academic and research centers. Geographical regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the leading gene fusion testing companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.

Report Includes
  • Overview and an analysis of the global market for gene fusion testing technologies
  • Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
  • Understanding of the technology background for fusion genes, their applications in cancer research and long-read transcriptome sequencing data
  • Estimates of the current market size and revenue prospects, along with a corresponding market share analysis based on the technology type, disease indication, end user and region
  • Facts and figures pertaining to the global market dynamics, opportunities and deterrents, technological advancements, regulations, prospects and the impact of macroeconomic factors
  • Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
  • Patent review, featuring key granted and published patents
  • Analysis of the industry structure, including companies’ market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Profiles of the leading companies in the market


Companies Mentioned

Amoy Diagnostics Co. Ltd.
Biocare Medical Llc.
Biocartis
F. Hoffmann-la Roche Ltd.
Guardant Health Inc.
Illumina Inc.
Integrated Dna Technologies Inc.
Myriad Genetics Inc.
Qiagen
Thermo Fisher Scientific Inc.

Table of Contents

79 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion
Chapter 2 Market Overview
Overview
Porter's Five Forces Analysis
Potential for New Entrants (Moderate)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (High)
Threat of Substitutes (Low)
Competition in the Industry (High)
Macroeconomic Factors Analysis
Healthcare Spending
Aging Population
U.S. Tariff Scenario
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Cancer
Rising Adoption of Personalized Medicine
Market Restraints
High Cost of Advanced Testing Method
Complex Reimbursement Coverage of Gene Fusion Testing
Market Opportunities
Emerging Markets
Increasing Awareness and Early Cancer Detection Programs
Market Challenges
Shortage of Skilled Professionals
Chapter 4 Emerging Technologies and Developments
Emerging Technologies
Single-Molecule Long-Read Sequencing
CRISPR-Based Fusion Detection
Digital PCR (dPCR) and Multiplex qPCR Assays
Artificial Intelligence (AI)
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Technology
Key Takeaways
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence in Situ Hybridization (FISH)
Immunohistochemistry (IHC)
Market Analysis by Indication
Key Takeaways
Solid Tumor
Hematological Cancer
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostic Laboratories
Academic and Research Centers
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 6 Competitive Intelligence
Key Takeaways
Competitive Landscape
Leading Companies of Gene Fusion Testing Market
Key Developments and Strategies
Chapter 7 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AMOY DIAGNOSTICS CO. LTD.
BIOCARE MEDICAL LLC.
BIOCARTIS
F. HOFFMANN-LA ROCHE LTD.
GUARDANT HEALTH INC.
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MYRIAD GENETICS INC.
QIAGEN
THERMO FISHER SCIENTIFIC INC.
Few Emerging Startups/Market Disruptors

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us